# Absorption, Distribution, Metabolism and Excretion (ADME) Study of BMS-986020

> **NCT02068053** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 6 (actual)

## Conditions studied

- Immunosuppression For Disease

## Interventions

- **DRUG:** [14C] BMS-986020

## Key facts

- **NCT ID:** NCT02068053
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2014-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02068053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02068053, "Absorption, Distribution, Metabolism and Excretion (ADME) Study of BMS-986020". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02068053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*